Samuel Perdue
2019 Member of the TBDWG
Samuel Perdue
Offering Grants For Lyme Vaccines in 2019
*
Targeted Prevention for Tickborne Diseases (R01 Clinical Trial Not Allowed)
NIH - National Institutes of Health (RFA-AI-19-037)
DEADLINES
- Proposal: 08/06/2019
Funding
- Amount: varies
- Duration: up to 5 years
Scope
The purpose of this Funding Opportunity Announcement (FOA) is to encourage the development of vaccines and other approaches for the prevention of Lyme disease and/or other tick-borne diseases.
This FOA is designed to encourage the research community to develop a range of approaches for preventing TBDs in humans using both established and novel technologies.
This FOA will support approaches including, but not limited to:
- Identifying and testing antigens for human vaccines against tick-borne pathogens
- Development and evaluation of vaccine candidates (excluding clinical trials)
- “Anti-tick” vaccines to elicit immune responses against tick salivary proteins or other antigens
- Reservoir-targeted vaccines to interrupt sylvatic transmission
- Other reservoir-targeted approaches to interrupt the natural history of infection
- Transgenic and para-transgenic approaches in ticks or reservoirs to interrupt tick-borne pathogen uptake, colonization, or transmission
Applications proposing the following will be considered non-responsive and will not be reviewed:
- Acaricide development
- Reservoir elimination
- Epidemiologic or surveillance studies, unless those studies are part of a broader application that focuses specifically on development of a targeted prevention
- Tick repellents or personal protection strategies
- Development and testing of mathematical algorithms for targeting tick or reservoir control methods
- Basic research on pathogenesis, host response, or tick or reservoir biology that is not part of a broader application focused specifically on development of a targeted prevention
- Clinical Trials
Applicants are highly encouraged to contact the program officials listed under Scientific/Research Contact(s) listed in Section VII to discuss their applications prior to submission to ensure research topics can be supported under this FOA.
Contact Information
Scientific/Research Contact(s)
Samuel S. Perdue, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3341
Email: sperdue@nih.gov
Link Here
scc